Pulse Biosciences, Inc. Marketable Securities (Current)
Pulse Biosciences, Inc. (PLSE) had Marketable Securities (Current) of $24.93 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2019-11-07
- 2019-09-30: Marketable Securities, Current $24.93M.
- 2019-06-30: Marketable Securities, Current $31.86M.
- 2019-03-31: Marketable Securities, Current $44.27M.
- 2018-12-31: Marketable Securities, Current $8.48M.
| Period end | Marketable Securities, Current |
|---|---|
| 2019-09-30 | $24.93M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $31.86M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $44.27M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $8.48M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $14.69M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $20.70M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $22.71M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $34.68M 10-Q · filed 2018-11-01 |
| 2017-09-30 | $9.62M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $13.41M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $16.11M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $14.31M 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |